Clinical trial
Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant and Late-Onset Hepatic Failure
NCT00225901 is registered in ClinicalTrials.gov with Kyoto University, Graduate School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant and Late-Onset Hepatic Failure
- Lead sponsor
- Kyoto University, Graduate School of Medicine
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- September 30, 2005
- Completion date
- Not reported
- Enrollment
- 16
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.